HCC1806 is an epithelial cell line isolated from the mammary gland of a 60-year-old, Black, female patient with acantholytic squamous cell carcinoma (ASCC), TNM Stage IIB, grade 2. …

2012年4月4日 · Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers.

2019年3月5日 · A comprehensive understanding of the epigenome and transcription profiling in HCC1806 provides the framework for evaluating efficacy and molecular mechanisms of …

A hyper-diploid cell line from mammary gland; breast; primary acantholytic squamous cell carcinoma, cells are homozygous for deletions in the FHIT gene at 3p14.2, held at ATCC, …

In the present study, a paclitaxel-resistant (TxR) HCC1806-derived breast cancer cell subline that harbored a MDR phenotype, with cross-resistance to anthracyclines and TBAs, was …

Evaluation of the sensitivity of two triple-negative breast cancer cell lines (HCC1806, HCC70) to a collection of dual mTOR and PI3K-like kinase (PIKK) inhibitors. Dataset 1 of 2: GR values.

2019年3月5日 · The human HCC1806 cell line is frequently used as a preclinical model for triple negative breast cancer (TNBC). Given that dysregulated epigenetic mechanisms are involved …

HCC1806 (人乳腺鳞状癌细胞) (STR鉴定正确) ￥1800. 现单独购买该产品也可享受限时优惠价！ 细胞培养最优解！ The HCC1806 breast cancer cell line was initiated on July 31, 1995, and …

HCC1806 Human epithelial mammary acantholytic squamous cell carcinoma cell line Established from the mammary gland of a 60-year-old, Black, female patient with acantholytic squamous …

HCC1806细胞系是从一位60岁的非洲裔女性患者的乳腺鳞状细胞癌（ASCC）中分离，患者被诊断为TNM IIB期2级肿瘤，病情无淋巴结转移，于1995年成功建立，历时10个月。 HCC1806细 …